Things seem relatively positive for the Australian share market and the $A.
While Coronavirus cases are still rising in many countries, the good news is that a vaccine is out there and there’s a good chance of reaching herd immunity globally by the end of 2021 or early 2022.
The wind-down to Christmas and the New Year is underway. But there are still a few statistical hurdles to clear before Christmas, including the all-important November labour force report.
The year may be coming to an end but there is no end to the amount of insightful data to assist investors with their investment and budget planning decisions.
Vaccine news keeps getting better and good returns for shares expected.
A quirk of the statistical schedule is that each change of season is ushered in by a barrage of economic data and events. And there will be more than a dozen indicators released over the first week of Summer.
Let’s take a look at the virus, the performance of the share market and whether Donald is saying good-bye yet.
In a huge week for Aussie investors, speeches from Reserve Bank Governor Philip Lowe will feature along with the Board’s November meeting minutes.
It’s now highly likely the outcome is a Biden Presidency, but no blue wave. This combination should be slightly more positive for Australian shares and the Australian dollar relative to US shares and the US dollar.
Catch up on the latest market and economic news from Australia and around the world.
The NAB business survey and a number of consumer sentiment surveys are in focus in the coming week.
Here’s the COVID-19 state of play and my views on who’ll win the US election.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox